1
|
Wu S, Wu Z, Ge Q, Zheng X, Yang Z. Antitumor activity of tridentate pincer and related metal complexes. Org Biomol Chem 2021; 19:5254-5273. [PMID: 34059868 DOI: 10.1039/d1ob00577d] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Pincer complexes featuring tunable tridentate ligand frameworks are one of the most actively studied classes of metal-based complexes. Currently, growing attention is devoted to the cytotoxicity of pincer and related metal complexes. The antiproliferative activity of numerous pincer complexes has been reported. Pincer tridentate ligand scaffolds show different coordination modes and offer multiple options for directed structural modifications. This review summarizes the significant progress in the research studies of the antitumor activity of pincer and related platinum(ii), gold(iii), palladium(ii), copper(ii), iron(iii), ruthenium(ii), nickel(ii) and some other metal complexes, in order to provide a reference for designing novel metal coordination drug candidates with promising antitumor activity.
Collapse
Affiliation(s)
- Shulei Wu
- Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy & Pharmacology, Affiliated Nanhua Hospital, University of South China, 28 Western Changsheng Road, Hengyang 421001, Hunan, PR China.
| | - Zaoduan Wu
- Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy & Pharmacology, Affiliated Nanhua Hospital, University of South China, 28 Western Changsheng Road, Hengyang 421001, Hunan, PR China.
| | - Qianyi Ge
- Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy & Pharmacology, Affiliated Nanhua Hospital, University of South China, 28 Western Changsheng Road, Hengyang 421001, Hunan, PR China.
| | - Xing Zheng
- Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy & Pharmacology, Affiliated Nanhua Hospital, University of South China, 28 Western Changsheng Road, Hengyang 421001, Hunan, PR China.
| | - Zehua Yang
- Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy & Pharmacology, Affiliated Nanhua Hospital, University of South China, 28 Western Changsheng Road, Hengyang 421001, Hunan, PR China.
| |
Collapse
|
2
|
Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure. Coord Chem Rev 2019. [DOI: 10.1016/j.ccr.2019.07.008] [Citation(s) in RCA: 74] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
3
|
Lapasam A, Banothu V, Addepally U, Kollipara MR. Synthesis, structural and antimicrobial studies of half-sandwich ruthenium, rhodium and iridium complexes containing nitrogen donor Schiff-base ligands. J Mol Struct 2019. [DOI: 10.1016/j.molstruc.2019.04.116] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
4
|
Pal M, Nandi U, Mukherjee D. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents. Eur J Med Chem 2018; 150:419-445. [DOI: 10.1016/j.ejmech.2018.03.015] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Revised: 03/02/2018] [Accepted: 03/03/2018] [Indexed: 10/17/2022]
|
5
|
Antimicrobial activity of cis-[Ru(bpy)2(L)(L′)]+ complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L′ = Cl− or CO. Polyhedron 2018. [DOI: 10.1016/j.poly.2018.01.002] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Lazarević T, Rilak A, Bugarčić ŽD. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem 2017; 142:8-31. [PMID: 28442170 DOI: 10.1016/j.ejmech.2017.04.007] [Citation(s) in RCA: 260] [Impact Index Per Article: 37.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2017] [Revised: 03/30/2017] [Accepted: 04/03/2017] [Indexed: 11/18/2022]
Abstract
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the metal, its oxidation state, the types and number of coordinated ligands and the coordination geometry. This review illustrates notable recent progress in the field of medicinal bioinorganic chemistry as many new approaches to the design of innovative metal-based anticancer drugs are emerging. Current research addressing the problems associated with platinum drugs has focused on other metal-based therapeutics that have different modes of action and on prodrug and targeting strategies in an effort to diminish the side-effects of cisplatin chemotherapy. Examples of metal compounds and chelating agents currently in clinical use, clinical trials or preclinical development are highlighted.
Collapse
Affiliation(s)
- Tatjana Lazarević
- University of Kragujevac, Faculty of Medicine, S. Marković 69, 34000, Kragujevac, Serbia
| | - Ana Rilak
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia.
| | - Živadin D Bugarčić
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia.
| |
Collapse
|
7
|
Lazić D, Arsenijević A, Puchta R, Bugarčić ŽD, Rilak A. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes. Dalton Trans 2016; 45:4633-46. [PMID: 26855406 DOI: 10.1039/c5dt04132e] [Citation(s) in RCA: 65] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
In this study, two representatives of previously synthesized ruthenium(ii) terpyridine complexes, i.e., [Ru(Cl-tpy)(en)Cl][Cl] (1) and [Ru(Cl-tpy)(dach)Cl][Cl] (2), were chosen and a detailed study of the kinetic parameters of their reactivity toward l-histidine (l-His), using the UV-Vis and (1)H NMR techniques, was developed. The inner molecular rearrangement from N3-coordinated l-His to the N1 bound isomer, observable in the NMR data, was corroborated by DFT calculations favoring N1 coordination by nearly 4 kcal mol(-1). These two ruthenium(ii) terpyridine complexes were investigated for their interactions with DNA employing UV-Vis spectroscopy, DNA viscosity measurements and fluorescence quenching measurements. The high binding constants obtained in the DNA binding studies (Kb = 10(4)-10(5) M(-1)) suggest a strong binding of the complexes to calf thymus (CT) DNA. Competitive studies with ethidium bromide (EB) showed that the complexes can displace DNA-bound EB, suggesting strong competition with EB (Ksv = 1.5-2.5 × 10(4) M(-1)). In fact, the results indicate that these complexes can bind to DNA covalently and non-covalently. In order to gain insight of the behavior of a neutral compound, besides the four previously synthesized cationic complexes [Ru(Cl-tpy)(en)Cl][Cl] (1), [Ru(Cl-tpy)(dach)Cl][Cl] (2), [Ru(Cl-tpy)(bpy)Cl][Cl] (3) and [Ru(tpy)Cl3] (P2), a new complex, [Ru(Cl-tpy)(pic)Cl] (4), was used in the biological studies. Their cytotoxicity was investigated against three different tumor cell lines, i.e., A549 (human lung carcinoma cell line), HCT116 (human colon carcinoma cell line), and CT26 (mouse colon carcinoma cell line), by the MTT assay. Complexes 1 and 2 showed higher activity than complexes 3, 4 and P2 against all the selected cell lines. The results on in vitro anticancer activity confirmed that only compounds that hydrolyze the monodentate ligand at a reasonable rate show moderate activity, provided that the chelate ligand is a hydrogen bond donor.
Collapse
Affiliation(s)
- Dejan Lazić
- Faculty of Medicine, Centre for Molecular Medicine and Stem Cell Research, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia
| | | | | | | | | |
Collapse
|
8
|
Li X, Heimann K, Li F, Warner JM, Richard Keene F, Grant Collins J. Dinuclear ruthenium(ii) complexes containing one inert metal centre and one coordinatively-labile metal centre: syntheses and biological activities. Dalton Trans 2016; 45:4017-29. [DOI: 10.1039/c5dt04885k] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Dinuclear ruthenium(ii) complexes containing one inert and one labile metal centre have been synthesised and their biological properties examined in bacterial and eukaryotic cells.
Collapse
Affiliation(s)
- Xin Li
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra
| | - Kirsten Heimann
- College of Marine & Environmental Sciences
- James Cook University
- Townsville
- Australia
- Centre for Biodiscovery and Molecular Development of Therapeutics
| | - Fangfei Li
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra
| | - Jeffrey M. Warner
- Centre for Biodiscovery and Molecular Development of Therapeutics
- James Cook University
- Townsville
- Australia
- College of Public Health
| | - F. Richard Keene
- Centre for Biodiscovery and Molecular Development of Therapeutics
- James Cook University
- Townsville
- Australia
- College of Science
| | - J. Grant Collins
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra
| |
Collapse
|
9
|
Mulyana Y, Keene FR, Spiccia L. Cooperative effects in homogenous water oxidation catalysis by mononuclear ruthenium complexes. Dalton Trans 2015; 43:6819-27. [PMID: 24647472 DOI: 10.1039/c4dt00629a] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The homogenous water oxidation catalysis by [Ru(terpy)(bipy)Cl](+) (1) and [Ru(terpy)(Me2bipy)Cl](+) (2) (terpy = 2,2':6',2''-terpyridine, bipy = 2,2'-bipyridine, Me2bipy = 4,4'-dimethyl-2,2'-bipyridine) under the influence of two redox mediators [Ru(bipy)3](2+) (3) and [Ru(phen)2(Me2bipy)](2+) (4) (phen = 1,10-phenanthroline) was investigated using Ce(4+) as sacrificial oxidant. Oxygen evolution experiments revealed that mixtures of both 2-4 and 2-3 produced more molecular oxygen than catalyst 2 alone. In contrast, the combination of mediator 4 and catalyst 1 resulted in a lower catalytic performance of 1. Measurements of the temporal change in the intensity of a UV transition at 261 nm caused by the addition of four equivalents of Ce(4+) to 2 revealed three distinctive regions-suggested to correspond to the stepwise processes: (i) [Ru(IV)=O](2+) → [Ru(V)=O](3+); (ii) [Ru(V)=O](3+) → [Ru(III)-(OOH)](2+); and (iii) [Ru(III)-(OOH)](2+) → [Ru(II)-OH2](2+). UV-Visible spectrophotometric experiments on the 1-4 and 2-4 mixtures, also carried out with four equivalents of Ce(4+), demonstrated a faster [Ru(phen)2(Me2bipy)](3+) → [Ru(phen)2(Me2bipy)](2+) reduction rate in 2-4 than that observed for the 1-4 combination. Cyclic voltammetry data measured for the catalysts and the mixtures revealed a coincidence in the potentials of the Ru(II)/Ru(III) redox process of mediators 3 and 4 and the predicted [Ru(IV)=O](2+)/[Ru(V)=O](3+) potential of catalyst 2. In contrast, the [Ru(IV)=O](2+)/[Ru(V)=O](3+) process for catalyst 1 was found to occur at a higher potential than the Ru(II)/Ru(III) redox process for 4. Both the spectroscopic and electrochemical experiments provide evidence that the interplay between the mediator and the catalyst is an important determinant of the catalytic activity.
Collapse
Affiliation(s)
- Yanyan Mulyana
- School of Chemistry and Australian Centre of Excellence for Electromaterials Science, Monash University, Victoria 3800, Australia.
| | | | | |
Collapse
|
10
|
Rilak A, Bratsos I, Zangrando E, Kljun J, Turel I, Bugarčić ŽD, Alessio E. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives. Inorg Chem 2014; 53:6113-26. [PMID: 24884156 DOI: 10.1021/ic5005215] [Citation(s) in RCA: 72] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
With the aim of assessing whether ruthenium(II) compounds with meridional geometry might be utilized as potential antitumor agents, a series of new, water-soluble, monofunctional ruthenium(II) complexes of the general formula mer-[Ru(L3)(N-N)X][Y]n (where L3 = 2,2':6',2″-terpyridine (tpy) or 4'-chloro-2,2':6',2″-terpyridine (Cl-tpy), N-N = 1,2-diaminoethane (en), 1,2-diaminocyclohexane (dach), or 2,2'-bipyridine (bpy); X = Cl or dmso-S; Y = Cl, PF6, or CF3SO3; n = 1 or 2, depending on the nature of X) were synthesized. All complexes were fully characterized by elemental analysis and spectroscopic techniques (IR, UV/visible, and 1D and 2D NMR), and for three of them, i.e., [Ru(Cl-tpy)(bpy)Cl][Cl] (3Cl), [Ru(Cl-tpy)(en)(dmso-S)][Y]2 [Y = PF6 (6PF6), CF3SO3 (6OTf)] and [Ru(Cl-tpy)(bpy)(dmso-S)][CF3SO3]2 (8OTf), the X-ray structure was also determined. The new terpyridine complexes, with the exception of 8, are well soluble in water (>25 mg/mL). (1)H and (31)P NMR spectroscopy studies performed on the three selected complexes [Ru(Cl-tpy)(N-N)Cl](+) [N-N = en (1), dach (2), and bpy (3)] demonstrated that, after hydrolysis of the Cl ligand, they are capable of interacting with guanine derivatives [i.e., 9-methylguanine (9MeG) or guanosine-5'-monophosphate (5'-GMP)] through N7, forming monofunctional adducts with rates and extents that depend strongly on the nature of N-N: 1 ≈ 2 ≫ 3. In addition, compound 1 shows high selectivity toward 5'-GMP compared to adenosine-5'-monophosphate (5'-AMP), in a competition experiment. Quantitative kinetic investigations on 1 and 2 were performed by means of UV/visible spectroscopy. Overall, the complexes with bidentate aliphatic diamines proved to be superior to those with bpy in terms of solubility and reactivity (i.e., release of Cl(-) and capability to bind guanine derivatives). Contrary to the chlorido compounds, the corresponding dmso derivatives proved to be inert (viz., they do not release the monodentate ligand) in aqueous media.
Collapse
Affiliation(s)
- Ana Rilak
- Faculty of Science, University of Kragujevac , R. Domanovića 12, P.O. Box 60, 34000 Kragujevac, Serbia
| | | | | | | | | | | | | |
Collapse
|
11
|
Lam PL, Lu GL, Hon KM, Lee KW, Ho CL, Wang X, Tang JCO, Lam KH, Wong RSM, Kok SHL, Bian ZX, Li H, Lee KKH, Gambari R, Chui CH, Wong WY. Development of ruthenium(II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus. Dalton Trans 2014; 43:3949-57. [PMID: 24448670 DOI: 10.1039/c3dt52879k] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
A series of ruthenium(II) bis(2,2'-bipyridyl) complexes containing N-phenyl-substituted diazafluorenes (Ru-C1, Ru-C6, Ru-C7 and Ru-F) was synthesized and their potential antibacterial activity against methicillin resistant Staphylococcus aureus (MRSA) was investigated. The Ru-C7 complex showed significant improvement in both minimum inhibitory concentration (MIC, 6.25 μg mL(-1)) and minimum bactericidal concentration (MBC, 25 μg mL(-1)) towards MRSA when compared with those of methicillin (positive control) (MIC = 25 μg mL(-1) and MBC = 100 μg mL(-1)). The Ru-C7 complex possessed much stronger antibacterial effects than the Ru-C6 complex (MIC, 25 μg mL(-1), MBC, >100 μg mL(-1)). Both Ru-C6 and Ru-C7 complexes were also demonstrated to be biologically safe when tested on normal human skin keratinocytes.
Collapse
Affiliation(s)
- P-L Lam
- State Key Laboratory of Chirosciences, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, P.R. China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Gorle AK, Ammit AJ, Wallace L, Keene FR, Collins JG. Multinuclear ruthenium(ii) complexes as anticancer agents. NEW J CHEM 2014. [DOI: 10.1039/c4nj00545g] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
The dinuclear ruthenium complex with X = H is four-times more cytotoxic than cisplatin against breast cancer cell lines; however, when X = NO2 the ruthenium complex is less active than cisplatin.
Collapse
Affiliation(s)
- Anil K. Gorle
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra, Australia
| | - Alaina J. Ammit
- Faculty of Pharmacy
- The University of Sydney
- Sydney, Australia
| | - Lynne Wallace
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra, Australia
| | - F. Richard Keene
- Centre for Biodiscovery and Molecular Development of Therapeutics
- James Cook University
- Townsville, Australia
- School of Pharmacy and Molecular Sciences
- James Cook University
| | - J. Grant Collins
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra, Australia
| |
Collapse
|
13
|
Xu L, Zhong NJ, Huang HL, Liang ZH, Li ZZ, Liu YJ. Synthesis, characterization, cellular uptake, apoptosis, cytotoxicity, dna-binding, and antioxidant activity studies of ruthenium(II) complexes. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2013; 31:575-91. [PMID: 22908949 DOI: 10.1080/15257770.2012.704110] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Two new ruthenium(II) polypyridyl complexes [Ru(dmb)(2)(HECIP)](ClO(4))(2) (1) (HECIP = N-ethyl-4-[(1,10)-phenanthroline(5,6-f)imidazol-2-yl]carbazole, dmb = 4,4'-dimethyl-2,2'-bipyridine) and [Ru(dmp)(2)(HECIP)](ClO(4))(2) (2) (dmp = 2,9-dimethyl-1,10-phenanthroline) have been synthesized and characterized. The DNA-binding behaviors of the two complexes were investigated by absorption spectra, viscosity measurements, and photoactivated cleavage. The DNA-binding constants for complexes 1 and 2 were determined to be 8.03 (± 0.12) × 10(4) M(-1) (s = 1.62) and 2.97 (± 0.15) × 10(4) M(-1) (s = 1.82), respectively. The results suggest that these complexes interact with DNA through intercalative mode. The photocleavage of pBR322 DNA by Ru(II) complexes was investigated. The cytotoxicity of complexes 1 and 2 has been evaluated by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)] method. Complex 1 shows higher anticancer potency than 2 against the four tumor cell lines. Apoptosis and cellular uptake were investigated. The antioxidant activities of the ligand and these complexes were also performed.
Collapse
Affiliation(s)
- Li Xu
- School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan, PR China
| | | | | | | | | | | |
Collapse
|
14
|
Pandrala M, Li F, Feterl M, Mulyana Y, Warner JM, Wallace L, Keene FR, Collins JG. Chlorido-containing ruthenium(ii) and iridium(iii) complexes as antimicrobial agents. Dalton Trans 2013; 42:4686-94. [DOI: 10.1039/c3dt32775b] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|